M Javad Aman

Abvacc, Inc.

NIH Rank #4570
  • R01 Holder
  • Early Career

NIH Funding · FY2024

Total Funding
$2.2M
Fiscal year 2024
Grants Awarded
3
Active NIH grants
National Rank
#4,570
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $2.2M across 3 grants · National rank #4570.

Top grants by award amount

M Javad Aman's NIH grant portfolio, ranked by award amount.

  • 5R44AI177045-02R44
    Prophylactic Immunotherapy for Marburg Virus Disease Outbreak Control
    $918.5K
    award amount
  • 5R01AI111205-08R01
    Multivalent Toxoid Vaccine for recurrent Staphylococccus aureus disease
    $649.4K
    award amount
  • 5R01AI146177-05R01
    Protective versus deleterious immune responses that impact vaccine efficacy against Staphylococcus aureus bloodstream infection
    $619.3K
    award amount

Affiliation

Institutions that have administered grants for M Javad Aman.

Affiliated with Abvacc, Inc. (MD).

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Abvacc, Inc.
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #4570
  6. 2024
    Entered Top 25% Nationally
    Ranked #4570

Related investigators

Other NIH-funded PIs frequently associated with M Javad Aman.